Cardiovascular Clinical Trial - HuyaBio - HBI-3000-402

Cardiovascular

Status:

Open to accrual

ClinicalTrials.gov:

NCT04680026

A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

Drug

HBI-3000, Placebo

Condition

Atrial Fibrillation